Ensol Biosciences Inc. (XKON: 140610)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,590
-210 (-1.64%)
Nov 15, 2024, 9:00 AM KST

Ensol Biosciences Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2017 FY 2016 FY 2015
Period Ending
Dec '17 Dec '17 Dec '16 Dec '15
Cash & Equivalents
721.34721.342,9216,064
Short-Term Investments
1,9011,9014,1591,501
Cash & Short-Term Investments
2,6222,6227,0807,565
Cash Growth
--62.96%-6.42%-
Accounts Receivable
48.6148.61-26.28
Other Receivables
5.735.7340.117.71
Receivables
104.34104.3440.1133.99
Prepaid Expenses
36.436.470.0327.59
Other Current Assets
87.1987.19106.4982
Total Current Assets
2,8502,8507,2977,709
Property, Plant & Equipment
4,2494,2494,4474,636
Long-Term Investments
---0
Other Intangible Assets
128.12128.12104.58127.59
Long-Term Deferred Charges
--266.16126.5
Other Long-Term Assets
393.9393.9747.7406.63
Total Assets
7,6217,62112,91213,056
Accrued Expenses
202.38202.38100.6289.1
Short-Term Debt
3030-1,680
Current Portion of Long-Term Debt
---180
Other Current Liabilities
83.9983.99467.6384.47
Total Current Liabilities
316.36316.36568.252,034
Other Long-Term Liabilities
32.532.524.1361.57
Total Liabilities
1,0571,0571,2022,581
Common Stock
4,1984,1984,1982,021
Additional Paid-In Capital
31,14931,14931,14926,340
Retained Earnings
-29,453-29,453-24,032-17,934
Comprehensive Income & Other
670.39670.39395.4747.76
Shareholders' Equity
6,5646,56411,71010,475
Total Liabilities & Equity
7,6217,62112,91213,056
Total Debt
3030-1,860
Net Cash (Debt)
2,5922,5927,0805,705
Net Cash Growth
--63.39%24.09%-
Net Cash Per Share
308.93308.93858.84849.11
Filing Date Shares Outstanding
8.398.398.246.72
Total Common Shares Outstanding
8.398.398.246.72
Working Capital
2,5342,5346,7285,675
Book Value Per Share
782.26782.261420.481558.92
Tangible Book Value
6,4366,43611,60510,347
Tangible Book Value Per Share
767.00767.001407.791539.93
Land
615.31615.31615.31615.31
Buildings
3,5823,5823,5823,582
Machinery
642.34642.34538.96428.76
Source: S&P Capital IQ. Standard template. Financial Sources.